---

---

tags : Cancer    symbols : Gsk   

save search

---

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -7.5% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -1.78% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 6.57% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -5.82% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $65.26 -4.38% 5.9K |

Manufacturing

| 27.29% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -14.84% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -10.24% | O: -0.2% H: 0.14% C: -0.48%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -4.1% | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -2.58% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| -1.84% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -4.03% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -4.84% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.67% | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 9.39% | O: -2.81% H: 2.08% C: 1.38%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -3.69% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

---

9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| Email alert Add to watchlist
VTRS | News A | $11.55 1.67% 1.65% 7.2M |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| Email alert Add to watchlist
JAZZ | $108.38 -1.18% -1.19% 400K |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| Email alert Add to watchlist
cancer cell global growth market

---

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 2.88% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 3.12% | O: 3.41% H: 0.0% C: -2.45%
VTRS | News A | $11.55 1.67% 1.65% 7.2M |

Health Technology

| -2.2% | O: -0.08% H: 3.47% C: -0.25%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -8.72% | O: -2.04% H: 0.19% C: -1.97%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 4.53% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 1.75% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -5.62% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $4.84 -5.65% -5.99% 310K |

Health Technology

| 1.36% | O: -0.1% H: 2.31% C: -1.26%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 5.95% | O: 0.82% H: 0.12% C: -1.64%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -13.23% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

---

Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published: 2024-01-04 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 1.69% | O: 2.46% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -7.71% | O: 0.49% H: 0.6% C: -0.83%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| -1.24% | O: 0.15% H: 1.88% C: -1.17%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -8.57% | O: -0.24% H: 1.43% C: 1.43%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -6.84% | O: 0.32% H: 0.93% C: 0.38%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 4.58% | O: -0.36% H: 0.98% C: 0.72%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -6.99% | O: -0.14% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 3.52% | O: -0.68% H: 0.87% C: 0.1%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -9.95% | O: -0.32% H: 0.44% C: 0.26%
america cancer immunotherapy market

---

Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 12.08% | O: 1.64% H: 0.0% C: -1.33%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 7.63% | O: 1.51% H: 0.13% C: -1.68%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.42% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 12.47% | O: -0.03% H: 0.28% C: -0.41%
BAX | $40.93 -0.22% 0.0% 2.2M |

Health Technology

| 14.33% | O: 0.14% H: 0.78% C: 0.22%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 16.07% | O: 0.26% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 11.23% | O: 0.73% H: 0.06% C: -1.38%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 0.79% | O: 0.2% H: 0.2% C: -0.76%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M |

Technology Services

| 23.36% | O: 1.97% H: 0.0% C: 0.0%
GOOG | News 4 | $161.05 0.71% 0.7% 19M |

Technology Services

| 23.57% | O: 1.97% H: 0.0% C: 0.0%
ADBE A | $477.11 0.89% 0.88% 2M |

Technology Services

| -20.77% | O: 0.97% H: 0.08% C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market

---

Changing the Trajectory of Breast Cancer in Europe: How Advanced Screening Can Make a Difference
Published: 2023-10-18 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 10.28% | O: 0.0% H: 0.0% C: -2.39%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 12.59% | O: -1.24% H: 0.06% C: -1.26%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -11.71% | O: -2.42% H: 0.0% C: 0.0%
breast cancer

---

Global Cancer Vaccine Industry Worth $13.4 Billion by 2030: Use of Nanosensors in Diagnosing Cancer Expected to Create Ample Opportunities for Key Players
Published: 2023-06-27 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 9.28% | O: -1.1% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 12.66% | O: -0.91% H: 0.56% C: -0.5%
MRNA | News S | $108.82 0.86% 0.85% 3.4M |

Health Technology

| -9.6% | O: 0.03% H: 0.37% C: 0.18%
DVAX | $11.42 -2.89% -2.98% 1.3M |

Health Technology

| -11.61% | O: 0.08% H: 1.31% C: 0.77%
vaccine expected cancer global

---

Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 9.28% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -16.11% | O: -0.95% H: 0.19% C: -0.32%
PFE | News 4 | $26.27 -0.19% -0.15% 23M |

Health Technology

| -28.79% | O: 0.19% H: 0.11% C: -1.46%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -1.17% | O: -0.01% H: 0.16% C: -0.32%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -9.47% | O: 0.03% H: 0.12% C: -0.24%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 12.66% | O: -0.91% H: 0.56% C: -0.5%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 61.72% | O: 2.15% H: 1.18% C: 0.43%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -24.59% | O: -0.06% H: 0.46% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| -0.74% | O: -0.21% H: 0.42% C: 0.13%
report business cancer treat global

---

New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
Published: 2023-06-08 (Crawled : 22:00) - biospace.com/
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 18.92% | O: 0.41% H: 0.68% C: 0.64%
PGEN | $1.42 1.43% 1.41% 560K |

Health Technology

| 7.58% | O: 0.0% H: 0.76% C: -4.55%
ONCY | $1.045 -3.24% -3.35% 180K |

Health Technology

| -30.82% | O: 0.63% H: 1.87% C: -1.25%
ITOS | $10.58 -3.73% -3.88% 150K |

Health Technology

| -31.94% | O: -0.52% H: 3.23% C: -2.2%
GILD | $67.07 0.06% 0.06% 8.3M |

Health Technology

| -11.83% | O: -0.42% H: 3.56% C: 3.48%
cancer

---

Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| -7.86% | O: 0.07% H: 0.0% C: -1.7%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 17.13% | O: 1.32% H: 0.0% C: -0.62%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -17.78% | O: -0.62% H: 0.88% C: 0.81%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -0.15% | O: 1.26% H: 1.08% C: 0.91%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 18.92% | O: 0.41% H: 0.68% C: 0.64%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 67.79% | O: -0.11% H: 2.66% C: 2.24%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -25.02% | O: 0.28% H: 0.42% C: -0.05%
BNTX | News | $88.18 -0.35% -0.35% 280K |

Health Technology

| -19.49% | O: 0.39% H: 0.15% C: -0.79%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| -2.88% | O: -0.23% H: 1.83% C: 1.52%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 23.39% | O: 0.0% H: 0.28% C: -0.23%
metabolic report cancer global therapeutics growth market

---

Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published: 2023-05-15 (Crawled : 17:00) - prnewswire.com
GNMSF | News | $290.34 3.83% 340 |

Health Technology

| -33.48% | O: 0.24% H: 0.66% C: 0.66%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 10.61% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -19.23% | O: 0.61% H: 0.3% C: 0.24%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -4.64% | O: 0.2% H: 0.13% C: -0.22%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 11.85% | O: 0.27% H: 0.6% C: 0.41%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -12.29% | O: 0.38% H: 0.0% C: 0.0%
GMAB | News | $28.47 -0.32% -0.32% 460K |

Health Technology

| -31.71% | O: 0.38% H: 0.91% C: 0.69%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 17.2% | O: 0.14% H: 0.28% C: 0.11%
report cancer global therapy growth market

---

Breast Cancer Screening Global Market Report 2023: Sector to Reach $2.12 Billion by 2028 at a 5.2% CAGR
Published: 2023-05-05 (Crawled : 22:00) - prnewswire.com
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| Email alert Add to watchlist
report breast reach cancer global market

---

Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including at the 2023 ASCO Annual Meeting
Published: 2023-04-26 (Crawled : 15:00) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 4.31% | O: -4.57% H: 0.22% C: -1.98%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 10.7% | O: -0.03% H: 0.3% C: -2.63%
ZNTL | $11.76 -6.44% -6.89% 850K |

Health Technology

| -45.98% | O: -0.23% H: 0.18% C: -1.43%
asco positive cancer meeting

---

Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including clinical support for Cyclin E1 expression as predictive marker for clinical benefit from azenosertib at the 2023 ASCO Annual Meeting
Published: 2023-04-26 (Crawled : 14:20) - globenewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 4.31% | O: -4.57% H: 0.22% C: -1.98%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 10.7% | O: -0.03% H: 0.3% C: -2.63%
ZNTL | $11.76 -6.44% -6.89% 850K |

Health Technology

| -45.98% | O: -0.23% H: 0.18% C: -1.43%
asco positive cancer meeting

---

Global Gastric Cancer Drugs Market Report 2023: Increasing Number of Obesity Cases and the Smoking Population Drives Growth
Published: 2023-04-20 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 7.3% | O: -0.08% H: 0.0% C: -0.68%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 10.64% | O: -0.24% H: 0.0% C: -1.03%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 97.64% | O: 0.25% H: 1.26% C: 0.92%
DHR | $250.41 -1.07% -0.72% 3.3M |

Health Technology

| -1.71% | O: -3.83% H: 1.9% C: 1.36%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -14.76% | O: -0.03% H: 0.0% C: 0.0%
obesity report cancer global growth market

---

Breast cancer therapeutics market size grow by USD 13.85 billion between 2021 to 2026; AbbVie Inc. and Amgen Inc., among others, emerge as key vendors - Technavio
Published: 2023-04-13 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 7.01% | O: 0.54% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -17.0% | O: -1.1% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| -8.08% | O: 0.0% H: 1.63% C: 1.63%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 19.63% | O: 1.25% H: 0.51% C: 0.51%
VTRS | News A | $11.55 1.67% 1.65% 7.2M |

Health Technology

| 17.62% | O: 0.31% H: 1.42% C: 0.71%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.95% | O: 1.3% H: 0.56% C: 0.51%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 8.35% | O: 0.85% H: 0.76% C: 0.76%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 3.35% | O: -0.84% H: 1.16% C: 1.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -15.16% | O: 0.29% H: 0.0% C: 0.0%
PBYI | $4.84 -5.65% -5.99% 310K |

Health Technology

| 65.98% | O: -0.34% H: 10.17% C: 6.9%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| -3.47% | O: 0.39% H: 1.05% C: 0.97%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 9.42% | O: -0.36% H: 1.33% C: 1.14%
abbvie breast cancer therapeutics market

---

Non-melanoma Skin Cancer Market size to grow at a CAGR of 5.76% from 2021 to 2026, Driven by the NMSC coverage and support - Technavio
Published: 2023-04-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 7.01% | O: 0.54% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 19.63% | O: 1.25% H: 0.51% C: 0.51%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.95% | O: 1.3% H: 0.56% C: 0.51%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 8.35% | O: 0.85% H: 0.76% C: 0.76%
BHC | $8.56 0.35% 0.0% 2M |

Health Technology

| 15.99% | O: 1.49% H: 3.07% C: 0.67%
ICAD | $1.56 3.8% 22K |

Technology Services

| 5.41% | O: 1.35% H: 0.0% C: -1.33%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 9.42% | O: -0.36% H: 1.33% C: 1.14%
cancer skin market

---

Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab-gxly) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemotherapy alone
Published: 2023-03-27 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 16.7% | O: 3.17% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 16.61% | O: 0.26% H: 0.17% C: -0.09%
ANAB | $19.25 0.37% 0.36% 390K |

Health Technology

| -12.01% | O: 0.23% H: 0.36% C: -1.59%
cancer treatment trial plus potential

---

Non-hodgkin lymphoma therapeutics market size to increase by USD 5,427.51 million between 2022 and 2027; Growing awareness about cancer as a key trend - Technavio
Published: 2023-03-24 (Crawled : 19:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| Email alert Add to watchlist
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| Email alert Add to watchlist
BAX | $40.93 -0.22% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| Email alert Add to watchlist
SGEN | $228.74 0.1% 20M |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| Email alert Add to watchlist
cancer growing therapeutics market

---

Skin Cancer Drugs Global Market Research Report 2023 with Focus on vismodegib (Erivedge) and sonidegib (Odomzo) - Forecasts to 2027 and 2032
Published: 2023-03-01 (Crawled : 02:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 13.75% | O: -2.15% H: 1.67% C: -0.03%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -1.42% | O: -1.29% H: 0.0% C: -0.13%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 37.72% | O: -1.3% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 16.92% | O: 0.18% H: 0.26% C: -0.53%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 19.23% | O: -0.15% H: 0.38% C: 0.12%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.31% | O: -0.11% H: 0.0% C: 0.0%
ICAD | $1.56 3.8% 22K |

Technology Services

| -41.13% | O: 1.13% H: 7.84% C: 5.97%
research global report skin cancer market

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---